# Concord Medical Services Holdings Ltd: financial statements, quarterly

CCM · NYSE · CIK 1472072 · [Healthcare](/sectors/healthcare.md)

Pages: [Overview](/companies/ccm.md) · [Financials](/companies/ccm/financials.md) · [Filings](/companies/ccm/filings.md) · [Insiders](/companies/ccm/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ccm/financials.md?period=annual).

## Balance sheet

| Line item | Unit | FY2014 (2014-12-31) | FY2015 (2015-12-31) | FY2016 (2016-12-31) | FY2017 (2017-12-31) | FY2018 (2018-12-31) | FY2019 (2019-12-31) | FY2020 (2020-12-31) | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [73.9](/filings/0001144204-16-097228.md) | [69.9](/filings/0001144204-17-023641.md) | [29.2](/filings/0001144204-18-023992.md) | [0.5](/filings/0001144204-19-022514.md) | [58.9](/filings/0001144204-19-022514.md) | [10.7](/filings/0001104659-20-054484.md) | [51.2](/filings/0001104659-21-126753.md) | [24.7](/filings/0001410578-22-001107.md) | [22.9](/filings/0001410578-23-000729.md) | [8.2](/filings/0001104659-24-049117.md) | [29.6](/filings/0001410578-25-000907.md) | [42.6](/filings/0001104659-26-050692.md) |
| Current assets | $m | [236](/filings/0001193125-15-148374.md) | [232](/filings/0001144204-16-097228.md) | [172](/filings/0001144204-17-023641.md) | [171](/filings/0001144204-18-023992.md) | [179](/filings/0001144204-19-022514.md) | [40.6](/filings/0001104659-20-054484.md) | [104](/filings/0001104659-21-126753.md) | [91.7](/filings/0001410578-22-001107.md) | [110](/filings/0001410578-23-000729.md) | [86.9](/filings/0001104659-24-049117.md) | [135](/filings/0001410578-25-000907.md) | [135](/filings/0001104659-26-050692.md) |
| Total assets | $m | [477](/filings/0001193125-15-148374.md) | [556](/filings/0001144204-16-097228.md) | [465](/filings/0001144204-17-023641.md) | [533](/filings/0001144204-18-023992.md) | [667](/filings/0001144204-19-022514.md) | [617](/filings/0001104659-20-054484.md) | [818](/filings/0001104659-21-126753.md) | [978](/filings/0001410578-22-001107.md) | [871](/filings/0001410578-23-000729.md) | [853](/filings/0001104659-24-049117.md) | [922](/filings/0001410578-25-000907.md) | [936](/filings/0001104659-26-050692.md) |
| Current liabilities | $m | [124](/filings/0001193125-15-148374.md) | [233](/filings/0001144204-16-097228.md) | [137](/filings/0001144204-17-023641.md) | [170](/filings/0001144204-18-023992.md) | [127](/filings/0001144204-19-022514.md) | [90.1](/filings/0001104659-20-054484.md) | [78.5](/filings/0001104659-21-126753.md) | [126](/filings/0001410578-22-001107.md) | [163](/filings/0001410578-23-000729.md) | [275](/filings/0001104659-24-049117.md) | [291](/filings/0001410578-25-000907.md) | [279](/filings/0001104659-26-050692.md) |
| Total liabilities | $m | [187](/filings/0001193125-15-148374.md) | [335](/filings/0001144204-16-097228.md) | [288](/filings/0001144204-17-023641.md) | [377](/filings/0001144204-18-023992.md) | [336](/filings/0001144204-19-022514.md) | [346](/filings/0001104659-20-054484.md) | [450](/filings/0001104659-21-126753.md) | [547](/filings/0001410578-22-001107.md) | [578](/filings/0001410578-23-000729.md) | [607](/filings/0001104659-24-049117.md) | [700](/filings/0001410578-25-000907.md) | [672](/filings/0001104659-26-050692.md) |
| Long-term debt | $m | [54.1](/filings/0001193125-15-148374.md) | [42.2](/filings/0001144204-16-097228.md) | [31.1](/filings/0001144204-17-023641.md) | [43.7](/filings/0001144204-18-023992.md) | [72.4](/filings/0001144204-19-022514.md) | [186](/filings/0001104659-20-054484.md) | [302](/filings/0001104659-21-126753.md) | [342](/filings/0001410578-22-001107.md) | [358](/filings/0001410578-23-000729.md) | [281](/filings/0001104659-24-049117.md) | [369](/filings/0001410578-25-000907.md) | [353](/filings/0001104659-26-050692.md) |
| Current portion of debt | $m | [39.7](/filings/0001193125-15-148374.md) | [54.2](/filings/0001144204-16-097228.md) | [11.9](/filings/0001144204-17-023641.md) | [30.3](/filings/0001144204-18-023992.md) | [6.4](/filings/0001144204-19-022514.md) | [6.2](/filings/0001104659-20-054484.md) | [19.1](/filings/0001104659-21-126753.md) | [25.6](/filings/0001410578-22-001107.md) | [49.9](/filings/0001410578-23-000729.md) | [102](/filings/0001104659-24-049117.md) | [52.5](/filings/0001410578-25-000907.md) | [78.7](/filings/0001104659-26-050692.md) |
| Short-term borrowings | $m | [51.9](/filings/0001193125-15-148374.md) | [87.4](/filings/0001144204-16-097228.md) | [81.0](/filings/0001144204-17-023641.md) | [78.7](/filings/0001144204-18-023992.md) | [57.7](/filings/0001144204-19-022514.md) | [41.0](/filings/0001104659-20-054484.md) | [3.8](/filings/0001104659-21-126753.md) | [21.4](/filings/0001410578-22-001107.md) | [24.4](/filings/0001410578-23-000729.md) | [45.0](/filings/0001104659-24-049117.md) | [89.0](/filings/0001410578-25-000907.md) | [61.5](/filings/0001104659-26-050692.md) |
| Shareholders' equity | $m | [290](/filings/0001193125-15-148374.md) | [215](/filings/0001144204-16-097228.md) | [168](/filings/0001144204-17-023641.md) | [144](/filings/0001144204-18-023992.md) | [63.6](/filings/0001144204-19-022514.md) | [(17.6)](/filings/0001104659-20-054484.md) | [(102)](/filings/0001104659-21-126753.md) | [(215)](/filings/0001410578-22-001107.md) | [(270)](/filings/0001410578-23-000729.md) | [(299)](/filings/0001104659-24-049117.md) | [(312)](/filings/0001410578-25-000907.md) | [(301)](/filings/0001104659-26-050692.md) |

- Cash and equivalents: us-gaap:Cash, us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

Shares outstanding: 130,251,685 at 2025-12-31, from the cover of the [20-F filed 2026-04-29](/filings/0001104659-26-050692.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:40 ET. No prices; not investment advice.